Sustained impact of subcutaneous immunotherapy among patients with allergic rhinitis who experienced treatment delay due to the COVID‐19 pandemic: A multicenter, two‐arm, real‐world study
Sign Up to like & getrecommendations! Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12122
Abstract: To the editor, Subcutaneous immunotherapy (SCIT) is highly effective for seasonal pollinosis and perennial disease in patients with mite allergy. SCIT usually involves administering a gradually increasing dose of the specific allergens to allergic patients… read more here.
Keywords: world; patients scit; scit delayed; scit scheduled ... See more keywords